Daewon Pharmaceutical Co., Ltd. (KRX:003220)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,150.00
-160.00 (-1.72%)
Last updated: May 21, 2026, 2:14 PM KST
Market Cap196.33B -32.6%
Revenue (ttm)605.43B +1.2%
Net Income-1.38B
EPS-87.38
Shares Out21.43M
PE Ration/a
Forward PE12.08
Dividend250.00 (2.60%)
Ex-Dividend DateDec 29, 2025
Volume22,845
Average Volume33,582
Open9,240.00
Previous Close9,310.00
Day's Range9,140.00 - 9,440.00
52-Week Range9,150.00 - 14,700.00
Beta0.27
RSI24.53
Earnings DateMay 22, 2026

About Daewon Pharmaceutical

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a thera... [Read more]

Sector Healthcare
Founded 1958
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003220
Full Company Profile

Financial Performance

Financial Statements